4 studies found for:    7271065 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
Condition: Asthma
Interventions: Drug: Albuterol  25 mcg, Placebo;   Drug: Albuterol 0.25 mcg;   Drug: Albuterol 90 mcg, Placebo;   Drug: Albuterol, 90 mcg;   Drug: Placebo;   Drug: Proventil 90 mcg
2 Completed Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006
Conditions: Asthma;   Bronchospasm;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Albuterol Inhalation Powder;   Drug: Placebo Control;   Drug: Active Comparator
3 Recruiting Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Condition: Asthma
Interventions: Drug: A006 DPI;   Other: Placebo DPI;   Drug: Proventil® MDI
4 Recruiting Asthma Inflammation Research
Conditions: Asthma;   Allergic Asthma;   Non-allergic Asthma
Intervention: Biological: Allergen

Indicates status has not been verified in more than two years